PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 121 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $4,730,000 | +63.0% | 1,244,815 | +118.4% | 0.00% | +50.0% |
| Q4 2019 | $2,901,000 | +380.3% | 570,002 | +377.0% | 0.00% | – |
| Q3 2019 | $604,000 | -29.3% | 119,502 | -13.7% | 0.00% | -100.0% |
| Q2 2019 | $854,000 | +91.9% | 138,452 | +44.3% | 0.00% | – |
| Q1 2019 | $445,000 | +30.1% | 95,952 | +17.9% | 0.00% | – |
| Q4 2018 | $342,000 | -32.9% | 81,352 | 0.0% | 0.00% | – |
| Q3 2018 | $510,000 | -22.0% | 81,352 | 0.0% | 0.00% | – |
| Q2 2018 | $654,000 | -7.4% | 81,352 | -14.1% | 0.00% | -100.0% |
| Q1 2018 | $706,000 | +25.4% | 94,652 | 0.0% | 0.00% | – |
| Q4 2017 | $563,000 | -19.2% | 94,652 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $697,000 | +8.4% | 94,652 | 0.0% | 0.00% | – |
| Q2 2017 | $643,000 | -71.7% | 94,652 | -60.6% | 0.00% | -100.0% |
| Q1 2017 | $2,270,000 | -42.1% | 240,432 | -47.0% | 0.00% | -33.3% |
| Q4 2016 | $3,921,000 | +468.3% | 453,842 | +316.6% | 0.00% | +200.0% |
| Q3 2016 | $690,000 | +50.0% | 108,952 | 0.0% | 0.00% | – |
| Q2 2016 | $460,000 | -27.1% | 108,952 | -24.7% | 0.00% | -100.0% |
| Q1 2016 | $631,000 | +0.5% | 144,652 | +41.1% | 0.00% | 0.0% |
| Q4 2015 | $628,000 | +7.9% | 102,482 | +0.7% | 0.00% | – |
| Q3 2015 | $582,000 | -23.3% | 101,752 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $759,000 | +39.5% | 101,752 | +11.8% | 0.00% | – |
| Q1 2015 | $544,000 | -20.9% | 91,052 | 0.0% | 0.00% | -100.0% |
| Q4 2014 | $688,000 | +45.5% | 91,052 | 0.0% | 0.00% | – |
| Q3 2014 | $473,000 | +20.7% | 91,052 | 0.0% | 0.00% | – |
| Q2 2014 | $392,000 | +69.7% | 91,052 | +61.1% | 0.00% | – |
| Q1 2014 | $231,000 | -5.3% | 56,523 | +23.4% | 0.00% | – |
| Q4 2013 | $244,000 | -13.5% | 45,823 | -18.4% | 0.00% | – |
| Q3 2013 | $282,000 | -4.7% | 56,123 | -15.5% | 0.00% | – |
| Q2 2013 | $296,000 | – | 66,427 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|